Bioequivalence Study of Metoprolol Succinate Extended Release Tablets 200 mg Under Fasting Conditions
Status:
Completed
Trial end date:
2013-03-01
Target enrollment:
Participant gender:
Summary
This is an open Label, randomized, two-period, two-treatment, two-sequence, crossover,
balanced, single dose pivotal study. The purpose of this study is to assess the
bioequivalence between Test Product and the corresponding Reference Product under fasting
condition in healthy adult human subjects.